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httpcense.Abstract Setting: Little is known on the concomitant occurrence of pulmonary fungal diseases in
patients with fungal rhino-sinusitis.
Objective: To evaluate presence of pulmonary fungal diseases in patients with fungal rhino-
sinusitis.
Patients and methods: A prospective study was done for 44 patients who fulﬁlled inclusion cri-
teria (sinus CT, and histopathological examination). All patients were assessed for pulmonary
symptoms, chest X-ray, CT scan, routine lab study, and broncho-alveolar lavage. Microscopic
examination of fungal hyphae, fungal culture, skin prick tests, total and speciﬁc IgE was done to
all cases.
Results: The mean age of patients was 32.5 ± 13.2. Fungal sinusitis was categorized into allergic
FS 24 (54.5%) 6 of them (25%) were asthmatic, fungus ball 16 (36.4%) four (25%) were asthmatic,
acute fulminant FS 3 cases (6.8%) one (33%) was asthmatic and chronic invasive sinusitis 1 (2.3%)
not asthmatic. Eleven cases (25%) had pulmonary symptoms mainly cough and wheeze, malaise 7
cases (16%), dyspnea and fever 6 cases (14%), weight loss 3 cases (7%) and expectoration of golden
brown cast in 2 cases (5%). Six patients (14%) had radiological involvement. Three cases (6%) in
allergic FS group had the diagnostic criteria for sino-bronchial allergic mycosis (SAM). One patient15454856.
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494 M.Sh. Badawy et al.was in acute stage I, second was in stage III corticosteroid dependant state, and third was in stage
1V of exacerbation with high total, speciﬁc IgE for Aspergillus fumigatus.
Conclusion: Universal screening for pulmonary fungal infection especially in patients with fungal
rhino sinusitis is highly recommended to treat it early, decrease morbidity and mortality of the dis-
eases.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
The relationship between upper airways and lower airways
has been studied for about 50 years. In this concept, upper
and lower airway diseases are considered as two manifesta-
tion of one pathologic process [1]. Sinopulmonary syn-
dromes result from diseases that affect both the paranasal
sinuses and the lower respiratory tract. Venarske and
deShazo, in 2002 [2], coined the term ‘sinobronchial allergic
mycosis’ (the SAM syndrome) to describe the expression of
fungal hypersensitivity in both upper and lower airways, this
was on the basis of ﬁve patients reported for their rare
presentations.
The three main clinical categories of aspergillus fungus are
allergic aspergillosis, invasive disease and saprophytic coloni-
zation [3]. Fungal rhinosinusitis has been described for many
years, initially in immunocompromised patients, but since
the development of nasal endoscopy, several new cases have
been reported in immunocompetent patients [4]. Millar and
colleagues [5] described the ﬁrst case of allergic aspergillosis
of the maxillary sinuses. Subsequently known as allergic asper-
gillus sinusitis (AAS), its clinico-pathological similarity to
ABPA was recognized [6].
Sher and Schwartz in 1988 [7] published the ﬁrst report of a
case of AAS with concurrent ABPA. Several such cases have
since been reported [8–10]. Fungal rhinosinusitis has been
separated into invasive and noninvasive forms. In cases of
acute fulminant invasive fungal sinusitis, patients are usually
immunocompromised and frequently the prognosis is poor
[11]. Allergic bronchopulmonary aspergillosis (ABPA), pre-
dominantly occurs in asthmatics. Aspergilloma is a fungal ball
that appears in a pre-existing cavity. These patients frequently
experience wheezing dyspnea with signs of airway obstruction
[12]. Cavities are not infrequent in ABPA, with formation of
an aspergilloma might be accelerated by therapy with cortico-
steroids [13].
The prevalence of concurrent ABPA and AAS is not
known. There have been very few studies which have evaluated
the presence of AAS in patients of ABPA and vice versa [14].
There is little knowledge on the concomitant occurrence of
pulmonary fungal diseases in patients with fungal rhino-
sinusitis.Aim of the study
This study aimed to investigate the presence of pulmonary
fungal diseases in patients with fungal rhino-sinusitis, and
identify which category of fungal affection (allergy or fungal
infections) in both upper and lower airways more liable to
occur simultaneously.Material and methods
A prospective study was started in March 2011; Patients with
clinical and documental diagnosis of fungal rhino sinusitis who
attended ENT department at Sohag University hospital were
invited to participate. The study was approved from the ethics
committee of our faculty of medicine. Procedures were ex-
plained and obtained written informed consent from the pa-
tients. Data obtained from the enrolled patients included
information about demographics, detailed medical history.
Criteria for inclusion and exclusion
Sixty patients with suspicious of fungal rhinosinusitis (FRS)
were assessed and evaluated using paranasal sinuses’ endo-
scopic surgical procedure with complete removal of fungal
contents from involved sinuses. Out of 60 patients 44 patients
were diagnosed FRS, based on clinical, radiological sinuses CT
scan, direct mycological and/or fungal culture and/or histo-
pathologic analysis. These patients who met the criteria of fun-
gal rhino-sinusitis were evaluated for detection of pulmonary
fungal diseases. Sixteen patients were excluded from the study
because four did not agree to participate in the study or sign
the informed consent term, and twelve patients did not meet
the above mentioned criteria.
All patients were subjected to Chest plain X-ray and CT
scan of which CT scans nose and paranasal sinuses.
Laboratory investigations
Hematological examination includes complete blood picture,
differential white blood cells especially absolute count of eosin-
ophil, and erythrocyte sedimentation rate. Blood chemistry in-
cludes blood sugar examination and liver, renal function tests.
Bacteriological examination
The ﬁrst early morning sample should be collected into a sterile
container. Culture and sensitivity test for non speciﬁc micro-
organism of the available samples repeated sputum smear
and culture for Mycobacterium tuberculosis were performed.
Pulmonary function tests
All subjects underwent complete pulmonary function testing
using (Medizintechnik mit System, JAEGER, TOENNIES,
Hoechberg/Germany) for conﬁrmation of the diagnosis of
bronchial asthma and assessment of its severity. Pre- and
post-bronchodilator tests were performed. Lung volumes and
ﬂows were measured and the normal values were considered
according to the European Respiratory Society references [15].
Table 1 Distribution of different patients’ groups according
to paranasal sinus mycosis.
Category of fungal sinusitis No. (%)
Group Allergic fungal sinusitis 24 (54.5)
Group Fungal ball 16 (36.4)
Group Acute fulminant FS 3 (6.8)
GroupV Chronic invasive FS 1 (2.3)
Total 44 (100)
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(ELISA)
The serum specimens were stored at 20 C until the time of
ELISA test performance [16]. Total serum immunoglobulin
E (LgE): Normal values are up to 200 IU/ml. Aspergillus
fumigatus (AF speciﬁc IgE): The test was considered to be po-
sitive if the result P0.35 IU/mL. A. fumigatus (AF speciﬁc
IgG): >12 U/ml was considered positive.
Skin prick test
The used antigens were A. fumigatus, Aspergillus ﬂavus and
Aspergillus niger. Histamine phosphate (5 mg/ml, as a positive
control) and negative control solutions were also used (the
antigens and positive and negative controls were supplied by
the Allergopharma Joachim Ganzer KG company) [17].
Specimens’ collection
The samples were sent for direct microscopic study, histopa-
thology in formalin solution and culture specimen was sent
in normal saline sterile bottles.
Bronchoalveolar lavage (BAL) samples
A sterilized ﬁberoptic bronchoscope was carried out in a stan-
dard fashion with diazepam and atropine sulfate for premedi-
cation; this followed by local anesthesia with lignocaine 10%
for the pharynx and lignocaine 2% for tracheobronchial
use. Fiberoptic bronchoscope was introduced by the nasal or
buccal route with the patient in a semi seated position or some-
times in the supine position. Thorough inspection of the tra-
cheobronchial tree was completed. Lavage is usually
performed in the right middle or upper lobe or in the lingual.
100–300 mL of saline is instilled in aliquots of 20–60 mL, the
ﬂuid is immediately aspirated at low pressure.
Direct microscopic examination
The specimen for fungal staining is mixed with 10% or 20%
potassium hydroxide (KOH) and examined.
Histopathology
Histopathologic techniques are more time-consuming but they
provide the only method of determining whether a fungus is
invading into host tissue by using hematoxylin and eosin
(H&E) stain.
Gomori methenamine silver (GMS) stain
It was used in all cases as it is more superior to H&E stains.
Fungal culture
All samples were placed into centrifuge tubes and sent to the
mycology laboratory within 24 h. Selection and inoculation
of culture media: Using non selective Sabouraud’s dextrose
agar (2%) [18].Diagnostic criteria and categorization of fungal rhino-
sinusitis:
1. Allergic fungal sinusitis: Five criteria for the diagnosis of
AFS: [19] nasal polyposis; allergic mucin; CT scan ﬁndings
consistent with chronic rhinosinusitis; Histological presence
of fungal hyphae, positive fungal culture; and type I hyper-
sensitivity (atopy) diagnosed by history, positive skin test,
or serology.
2. Fungal ball: Patients with symptoms of unilateral or bilat-
eral nasal obstruction, pressure feelings and nasal discharge
with the detection of a mass of mycelia embedded in mucus
within the paranasal sinuses without mucosal invasion on
histopathology [11].
3. Acute fulminant fungal sinusitis: It is described by a time
course of <4 weeks caused by rapid spread of fungi from
the nasal mucosa and sinuses into the orbit, vessels, and
brain parenchyma. ‘‘Prognosis is poor,’’ This is character-
ized by evidence of angio-invasion by fungal hyphae [20].
4. Chronic invasive fungal sinusitis: The disease typically has a
time course of >12 weeks characterized by mass of hyphae,
occasional presence of vascular invasion, and sparse inﬂam-
matory reaction inassociationwith involvementof local struc-
tures. The mass of hyphae may extend into the brain [21].Statistical analysis
All statistical analyses were performed using the SPSS statisti-
cal package (version 11 for Windows, SPSS; Chicago, Ill.,
USA). The association and relationship between 2 quantitative
variables were evaluated with Chi-square test. The results were
expressed as the means and standard deviation for quantitative
variables and as frequencies for categorical ﬁndings. To com-
pare the means of 2 independent groups, Student’s t test was
used. The level of statistical signiﬁcance was taken as p
value < 0.05.
Results
Total of forty fourpatientswas enrolled in the study.Themeanage
of patients was 32.5 ± 13.2 years ranging from 11 to 60 years with
21 (48%) male and 23 (52.3%) female. The patients diagnosed as
having paranasal sinus mycoses were categorized into four disease
groups. Allergic FS was noted in 24 (54.5%), fungal ball in 16
(36.4%), acute fulminant FS in 3 (6.8%) and chronic invasive FS
in 1 (2.3%) as shown in (Table 1).
Out of 24 patients of AFS 13 were males and 11 were fe-
males with the mean age of 26.97 years. None of the patients
were immune-compromised. Among the AFS group 6 (25%)
were asthmatic. Two cases (8%) had aspirin hypersensitivity,
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sal polyposis, asthma, and aspirin intolerance. Sixteen cases
(66.7%) had elevated total serum IgE. Three cases exceeded
1000 IU/mL. Mean serum levels of Aspergillus speciﬁc IgE
were 0.3942 ± .2330 and elevated in 14 (58.3%) cases of
AFS. Mean serum levels of Aspergillus speciﬁc IgG were
11.24 ± 7.2 and was elevated in 11(45.8%) cases of AFS. Only
skin test reactivity and total serum immunoglobulin E showed
a signiﬁcant difference among the AFS and non-AFS groups
regarding atopy (P< 0.05) (Table 2).
Thirteen patients had positive fungal culture. Aspergillus
was recovered on culture in 13(54.2%) cases and no fungal
growth was reported in 11 (45.8%) cases. A. fumigatus was a
single fungus isolated in 10 cases.
A. fumigatus grew combined with A. niger in one case.
Three Aspergillus species (A. fumigatus, A. ﬂavus and A. niger)
were isolated in one case. Candida albican was also grown in
addition to A. niger in one case in the allergic fungal sinusitis
group (Figs. 1–3).
Fungus ball (16 cases, 36.4%)
Out of 16 patients 10 (62.5%) were females and 6 (37.5%) were
males with the mean age of 41.68 years. All patients were im-
mune-competent. Nine of the patients (56.25%) have been
subjected to homolateral endodontic surgery in the past. Four
(25%) patients were asthmatic, two cases (12.5%) had aspirin
hypersensitivity, 3 (18.5%) had elevated total IgE level. Only
total IgE and skin test reactivity showed a signiﬁcant differ-
ence among the AFS and non-AFS groups regarding atopy
(P< 0.05). There were statistically signiﬁcant differences be-
tween AFS and fungus ball groups as regards total IgE, spe-
ciﬁc IgE and IgG for aspergillus. Tables 3 and 4.
Acute fulminant FS (3 cases, 6.8%)
Three patients were acute fulminant FS in our study, including
two males and one female. Their ages were 19, 22 and 34. Two
of the three patients died. All had an underlying diseases asso-
ciated with immune compromised status. Case no. 1 is a
19 year old female patient, presented with fever, ulceration of
palatal mucosa, facial anesthesia and mental status changes.
She had neutropenia and renal failure. Case no. 2 is a 22 year
old male patient, presented with fever, severe headache and
ophthalmologic complaints, including proptosis, periorbital
pain and decreased visual acuity. He had neutropenia. Case
no. 3 is a 34 year old male patient, presented with fever and
localizing symptoms of rhinosinusitis. He had uncontrolled
diabetes. CT scan revealed evidence of invasion. Culture inTable 2 Comparing atopic state among AFS and non-AFS groups
Variables AFS (24 cases)
No. %
Asthmatic 6 (25%)
Aspirin hypersensitivity 2 (8.3%)
High total IgE 16 (66.7%)
Positive skin test 14 (58%)
Peripheral eosinophilia 10 (41%)these patients revealed Mucormycosis in two cases (Fig. 4)
and Aspergillus species in the third case.
All cases had negative skin test reactivity to Aspergillus
antigen. Lab investigations showed increased level of total ser-
um IgE in one case. Serum levels of Aspergillus speciﬁc IgE
and Aspergillus speciﬁc IgG were negative.
Chronic invasive FS (1 case, 2.3%)
A 42 year old immunocompetent female presented with
8 month history of chronic rhinosinusitis; a month history of
painless proptosis of the left eye. She denied diplopia, head-
aches or change in vision. CT scan of the paranasal sinuses re-
vealed a mass involving the left orbit with invasion of the
medial wall of the maxillary sinus, lamina papyrecea and the
nasal septum. Mucosal invasion by fungus was also identiﬁed.
Aspergillus culture was negative. Immunological tests were
negative.
Presence of pulmonary fungal diseases in patients with fungal
rhino-sinusitis
Eleven patients (25%) had pulmonary symptoms mainly
cough, dyspnea, malaise, (Table 5) and all of them were asth-
matics. Of these 11 patients, the preliminary radiography of
the chest revealed pulmonary involvement in 6 patients
(14%). After laboratory investigations including; histopathol-
ogical examination, bacteriological examination (stain to ex-
clude acid fast bacill, culture and sensitivity test for non
speciﬁc micro-organism), fungal culture and immunological
workup (skin test, total serum immunoglobulin E, A. fumiga-
tus ‘‘AF IgE’’ and A. fumigatus ‘‘AF IgG’’) were performed.
Conﬁrmation of pulmonary fungal diseases was available in
three patients (6.8%). All had positive family history of asth-
ma and or rhinitis, hyphae, positive culture and positive
GMS stain.
These three cases were found in allergic fungal sinusitis
group and had the full diagnostic criteria of sinobronchial
allergic mycosis (SAM). One of them had Allergic bronchopul-
monary aspergellosis (ABPA) plus AFS and pulmonary fun-
gus ball. Cough and expectoration were the predominant
symptoms in all the three patients, also were observed to have
wheezing and fever during exacerbation, while dyspnea and
chest pain were reported by two cases. Passage of golden
brown casts along with sputum was reported by two patients,
while one patient had hemoptysis, who had an aspergilloma
(Table 6).
The three patients who diagnosed as having Allergic
(ABPA) can be subdivided according to the stage of Allergicin 44 FRS patients.
Non AFS (20cases) P value
No. %
5 (25) 1.00
2 (10) 0.848
4 (20) 0.003
3 (15) 0.003
7 (35) 0.651
Figures 1–3 Three Aspergillus species (Aspergillus fumigatus, Aspergillus ﬂavus and Aspergillus niger) growth on Sabouraud’s agar.
Table 3 Atopic state among AFS and fungus ball groups.
Variables AFS (24 cases) Fungus ball (16 cases) P value
No. % No. %
Asthmatics 6 25 4 25 0.64
Aspirin sensitivity 2 8.3 2 12.5 0.52
High total IgE 16 66.7 3 18.5 0.003
Positive skin test 14 58 3 18.5 0.01
Eosinophilia 10 41.7 6 37.5 0.42
Table 4 Comparing both means of total serum IgE, serum levels of Aspergillus speciﬁc IgE and serum levels of Aspergillus speciﬁc
IgG among the AFS and fungus ball groups.
Variables Category of fungal sinusitis Mean ± SD P value
Total IgE AFS 24 cases 521.96 ± 446.60 0.003
Fungus ball 16 cases 136.94 ± 107.43
Speciﬁc aspergillus IgE AFS 0.39 ± .2330 0.001
Fungus ball 0.18 ± 7.719E-02
Speciﬁc aspergillus IgG AFS 11.246 ± 7.297 0.002
Fungus ball 6.475 ± 2.476
Figure 4 Mucor is a rapidly growing fungus which will ﬁll a
culture plate in a matter of a few days with a woolly growth
resembling cotton candy. New growth is white in color but turns a
greyish-brown with aging.
Table 5 Pulmonary manifestations in patients with fungal
rhinosinusitis.
Variable No. (%)
Cough 11 (25.00)
Chest pain 2 (4.54)
Hemoptysis 1 (2.27)
Wheeze 11 (25.00)
Sputum production 8 (18.18)
Passage of golden brown casts 2 (4.54)
Dyspnea 6 (13.63)
Fever 6 (13.63)
Weight loss 3 (6.82)
Malaise 7 (15.91)
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stage) as the patient is known to have ABPA, asthmatic, radio-
logical central bronchiectasis, the IgE level was markedly ele-
vated (1034 IU/mL), A. fumigatus IgE was elevated (0.75 IU/mL), A. fumigatus IgG was elevated (19 U/mL), and with
peripheral eosinophilia, Patient No. 2 in the stage IV (the cor-
ticosteroid-dependent stage) the patient was steroid-dependent
with attempted to taper the steroid therapy, resulting in an
obvious worsening of symptoms and the radiological central
bronchiectasis. The serum IgE level was elevated (950 IU/
Table 6 Clinical pulmonary proﬁle of three patients with
concomitant ABPA and AFS.
Case number 1 2 3
Age/sex 26/M 30/M 40/F
Chest manifestations
Duration of illness (yr) 4 1 2
Cough + + +
Expectoration + + +
Plugs/casts +  +
Wheeze + + +
Dyspnea +  +
Chest pain +  +
Hemoptysis +  
Fever + + +
Weight loss +  
Malaise +  +
Family history
Asthma Father  Sister
Rhinitis Father Mother 
Past treatment: Antibiotics + + +
Decongestants + + +
Antituberculous therapy +  
Steroid therapy + + +
Asprin intolerance +  
Table 7 Laboratory data of three patients with concomitant
ABPA and AFS.
Case Number 1 2 3
BAL/sputum specimen AFB smear +  
Eosinophilic inﬁltration + + +
Fungal culture + + 
Fungal hyphea: H&E stain + + 
GMS stain + + +
Spirometry: FVC (%) 67.00 85.00 71.00
FEV1(%) 59.00 81.00 54.00
FEV1/ FVC(%) 88.05 95.30 76.05
Skin test + + +
Total IgE (IU/mL) 1034 950 1786
Aspergillus fumigatus IgE (IU/mL) 0.75 0.68 0.95
Aspergillus fumigatus IgG (U/mL) 19.0 17.0 34.0
498 M.Sh. Badawy et al.mL), A. fumigatus IgE was elevated (.68 IU/mL), A. fumigatus
IgG was elevated (17 U/mL), and with peripheral eosinophilia,
Patient No. 3 in the Stage1 (acute stage), is asthmatic, radio-
logical pulmonary inﬁltrates and central bronchiectasis, the
IgE level was markedly elevated(1786 IU/mL), A. fumigatus
IgE was elevated (0.95 IU/mL), A. fumigatus IgG was elevated
(34.0 U/mL), and with peripheral eosinophilia,
Plain chest X-ray revealed central bronchiectasis (CB) with
normal peripheral bronchi, a diagnostic feature of ABPA, and
transient pulmonary inﬁltrates in all the three patients. Com-
puted tomography conﬁrmed the features of chest X-ray ﬁnd-
ings. The patient who had an aspergilloma concomitant with
Allergic (ABPA) revealed loculated hydropnemothorax in
the right lung. Solitary well deﬁned mycelial mass occupying
a cavity in the left middle lobe. The cyst wall is smooth and
thin.
Pulmonary histopathological examination
Cytological examination of the material obtained with bron-
chial brushing disclosed numerous eosinophils, Charcot–Ley-
den crystals and fungal structures morphologically
corresponded to A. fumigatus in all cases. About lung function
test; the three cases were asthmatic and had a forced expiratory
volume in 1 second (FEV1) of less than 80% of normal. One of
them had ABPA with normal lung volumes and ﬂow rates,
even in the presence of bronchiectasis. PFT in the other two
patients showed reduction in total lung capacity, forced vital
capacity (FVC), forced expiratory volume in the ﬁrst second
(FEV1). Arterial blood gas analysis showed only mild hypox-
emia (pO2 9 kPa). Positive hypersensitivity reactions were ob-
served in all three patients. Total IgE was raised in all three
patients. A. fumigatus IgE/IgG was positive by ELISA in threepatients. Peripheral eosinophilia was observed also in the three
patients as shown in (Table 7).
There is insigniﬁcant difference between AFRS group to
non allergic fungus group as regards the incidence of pulmon-
ary affection, P value = 0.153 but there is also a signiﬁcant
positive strong correlation between total serum IgE and A.
fumigatus IgE.
Discussion
In spite of similar histopathological features between the aller-
gic mucin of AAS and the mucous plugs of ABPA, concomi-
tant occurrence of ABPA and AAS appears to be rarely
reported and there have been very few studies consisting of
case reports which have evaluated the presence of AAS in pa-
tients of ABPA and vice versa [14,22]. Forty four patients were
categorized into four pathologic groups: (1) allergic fungal
sinusitis in 24 cases (54.5%) (2) mycetoma/fungus ball in 16
cases (36.4%); (3) acute fulminant fungal sinusitis in 3 cases
(6.8%); and (4) chronic invasive fungal sinusitis in 1 case
(2.3%). These results matched with Montone et al., 2012 [23]
who reported 45% AFRS, 40% FB, 2% combined AFRS
and FB and 12.5% were invasive 11% AIFRS and 1.2% CIF-
RS. M.T. Hedayati et al., 2010 [24] reported higher incidence
of AFRS (80%), followed by FB (20%) as well as Granville
et al., 2004 [25] who reported that allergic FS is the most fre-
quent and accounts for 72% of cases, followed by chronic non-
invasive FS (23%), whereas both chronic invasive and acute
fulminant FS are quite rare.
Studying of 44 patients with fungal rhinosinusitis proved
the presence of concomitant ABPA in three patients of the
24 patients who had allergic fungal sinusitis. Association of
ABPA, AFS and aspergilloma in the same patient was found
only in one case. This conﬁrms that the pathogenesis of ABPA
and AFS is similar to each other, and differs from any other
fungal rhinosinusitis category. In addition patients with AFS
are at risk of developing ABPA and vice versa. This is consis-
tent with multiple studies [2,9,26,27]. Venarske and deShazo in
2002 have termed this process the SAM syndrome, an acronym
for sinobronchial allergic mycosis [2].
The affected patients were 2 men and a woman, age range
of 26–40 years. All had a history of asthma and chronic sinus-
itis and family history of asthma and/or rhinitis. These ﬁndings
are consistent with Venarske and Shah [2,27]. Past history of
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who had an aspergilloma, while Shah et al., 2001 [27] reported
ﬁve cases. All the three patients had history of passage of nasal
golden brown casts and two of them were presented by passage
of golden brown casts along with sputum beside the dyspnea
and chest pain. Hemoptysis was the alarming presentation of
only one patient, who had an aspergilloma. Attapattu in
1991 [28] reported that passage of golden brown casts along
with sputum is one of the minor criteria for the diagnosis of
ABPA.
In this study patients with SAM are atopic individuals; all
the 3 cases had asthma, peripheral eosinophilia, positive skin
test reactions and high levels of total IgE. Only one gave his-
tory of aspirin intolerance. Patients with SAM showed high
levels of total IgE, two of them exceeded 1000 IU/mL and
the other patient’s level was 950 IU/mL, and this stressed that
AFS patients with high levels of total IgE could be at risk for
the development of ABPM. These ﬁndings are also in agree-
ment with Venarske and deShazo in 2002 [2]. Shah and Sircar
in 1991 [29] stated that both AFS and ABPA have the same
mechanism, which is likely that the release of antigenic mate-
rial from Aspergillus sets into motion a chain of immunologic
reactions leading to the development of both AFS and ABPA.
Chest radiographic ﬁndings revealed central bronchiectasis
in the three patients; besides hydropnemothorax in the right
lung. Solitary well deﬁned mycelial mass occupying a cavity
in the left middle lobe of the patient who has association of
ABPA, AFS and aspergilloma. Venarske and deShazo in
2002 and Shah et al., 2001 [2,27] reported that all had radio-
graphic evidence of central bronchiectasis which is essential
pathognomic feature of ABPA as documented by Scadding
in 1967 [30].
Consequently, ABPA patients with nasal CT revealing dou-
ble dense lesions should be investigated carefully to exclude
AFS. As well, AFS patients with central bronchiectasis de-
tected by chest radiography are considered as APBA until
investigated. The histopathologic ﬁndings of both nasal aller-
gic mucin and bronchoalveolar lavage of the three patients
showed the same features, eosinophilic mucin contained Char-
cot–Leyden crystals and fungal hyphae were noted within the
‘‘allergic mucin’’, support that these are similar hypersensitiv-
ity reactions to fungal elements occurring at different locations
in the same airway and the pathogenesis of these diseases is
similar.
In this study culture of bronchial samples Aspergillus spe-
cies in all affected cases and repeated sputum stains and cul-
ture were negative for M. tuberculosis in all cases. This is in
agreement with Shah et al., 2001 [27]. In the current study pul-
monary function test revealed obstructive ventilator defect in
two of the three patients, while Shah et al., 2001 [27] reported
obstructive ventilator defect in all his studied seven patients.
This result is not pathognomic for ABPM, but when AFS pa-
tient presented with obstructive ventilator defect; the physician
should be alert to the possibility of coexistent ABPA or just
asthma. In the current study, one patient presented with an
association of ABPA, AFS and aspergilloma, the patient was
asthmatic, had a history of corticosteroids therapy and past
history of receiving anti-tuberculous treatment. It is not known
if aspergilloma preceded ABPA or ABPA was developed ear-
lier. This was in agreement with Sharma et al [13].
Among the AFS patients, 6 (25%) were asthmatic, only 2
patients (8%) had a history of aspirin intolerance; one of themfulﬁlled the criteria of Samter’s triad. Comparison between
AFS group and non-AFS group revealed there is statistically
insigniﬁcant difference among these 2 groups in relation to
asthma, aspirin sensitivity, and peripheral blood eosinophilia.
The signiﬁcant differences were founded in the positive skin
test reactivity and elevated total IgE, while Bee et al., in
2005 [31] showed statistically insigniﬁcant difference in relation
to asthma, aspirin sensitivity, and total IgE. The only signiﬁ-
cant issue was the positive skin test reaction; he revealed also
two AFS patients were identiﬁed as having Samter’s triad.
Cody et al., in 1994 [32] described a higher incidence of aspirin
sensitivity in AFS patients of 27%.
Conclusion
Patients with asthma and/or rhinosinusitis along with sensiti-
zation to aspergillus antigens are at an increased risk of devel-
oping ABPA and/or AAS. ABPA must be excluded in all
patients with AAS and vice versa. Patients who presented with
passage of nasal and sputum plugs should alert the physician
to the possibility of coexistent ABPA and AAS. Presence of
hemoptysis in ABPA patient considers an alarming manifesta-
tion for developing aspergilloma.
AFS patient presented with highly elevated total IgE should
raise the suspicion of having ABPA. Presence of double dense
lesions in the nasal CT and central bronchiectasis in the chest
radiography of the same patient should strengthen the suspi-
cion of having concomitant ABPA and AFS in this patient.
There is evidence that only AFS category has similar immu-
nological pathogenesis to ABPA and not any other category of
fungal rhinosinusitis as these immunological similarities be-
tween ABPM and AFS are not present in the immunological
laboratory ﬁndings of FB, AIFS and CIFS.
Universal screening for pulmonary fungal infection espe-
cially in patients with fungal rhino sinusitis is highly recom-
mended. There is an urgent need to treat it early to decrease
morbidity, mortality and alter the course of the diseases.
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